
معرفی
Dr. Sundeep Vedithi is a College Research Associate at the University of Cambridge specializing in Biochemistry, with a doctoral degree in Molecular Biology and Immunology of leprosy from India and twelve years of laboratory-based research experience in genomics, transcriptomics, immune biomarkers, and computational biology.
His educational background centers on Molecular Biology and Immunology of leprosy, reflecting his deep expertise in infectious disease mechanisms.
Vedithi's research focuses on translational applications for leprosy and neglected tropical diseases, integrating genomics, transcriptomics, and computational biology to develop diagnostics and therapeutics. He leads initiatives translating laboratory findings into practical solutions to reduce the global burden of leprosy, with emphasis on drug discovery, immune signature identification, and antimicrobial resistance detection.
His notable scientific awards include:
- International Young Scientist Award for Best Poster presentation (19th International Leprosy Congress, Beijing 2016)
- International Young Scientist Award for Best ePoster presentation (18th International Leprosy Congress, Brussels 2013)
- Acworth Leprosy Hospital Society Award for Best Scientific Paper Presentation (IAL-LEPCON 2014)
- Best Oral Presentation Award at Indian Academy of Science and Nature Conference (2011)
- Summer Research Fellowship from Jawaharlal Nehru Center for Advanced Scientific Research (2004)
Vedithi has secured substantial research funding as PI/Co-PI for multicentric projects:
- Structure Guided Fragment-based Drug Discovery for Leprosy (American Leprosy Missions, University of Cambridge) - Co-PI
- Structure Guided Fragment-based Drug Discovery for SARS-CoV-2 (University of Cambridge) - Senior Research Associate
- Leprosy-associated transcriptomic and immune signatures for reaction determination (SIH-R&LC/Leprosy Research Initiative) - Co-PI
- Whole transcriptome/genomic profiling of drug-resistant Mycobacterium leprae (SIH-R&LC/ICMR) - Co-PI
- Innovative DNA technologies for AMR detection in leprosy (SIH-R&LC/American Leprosy Missions) - PI
- Validation of Biomeme FranklinTM Mobile qPCR for Mycobacterium ulcerans (KCCR Ghana/American Leprosy Missions) - PI
He directs global health initiatives as Chair of WHO Buruli Ulcer Laboratory Network, Co-Chair of Global Partnership for Zero Leprosy Diagnostics Working Group, and Member of WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases.




